28.12.2015 09:22:00

Canberra Sale : Mirion-Charterhouse Project Selected

Regulatory News:

After analyzing bids, meeting on wednesday, December 23rd 2015, and being consulted again on thursday, December 24th, the Areva (Paris:AREVA) Board of Directors selected the Mirion-Charterhouse* offer for the acquisition of its subsidiary Canberra. Canberra is specialized in nuclear instrumentation and measurement. The sale is part of the transformation plan pursued by AREVA to refocus its business on nuclear cycle processes.

In the coming weeks the project will be subject to consultation with Canberra employees' representative bodies and the bid will need to be approved by the competition authorities. The purpose of the parties is to complete the sale process by the end of year 2016.

* Mirion is a group specialized in radiation protection equipment, radiation detection and monitoring systems, and dosimetry services.
Charterhouse is a leading independent private equity house operating in Europe. Charterhouse has assets under management of 6.7 billion euros and, since its creation, has completed 140 transactions worth an aggregate in excess of 50 billion euros in value. Charterhouse is Mirion’s majority owner.

MORE ABOUT AREVA

AREVA supplies high added-value products and services to support the operation of the global nuclear fleet.
The company is present throughout the entire nuclear cycle, from uranium mining to used fuel recycling, including nuclear reactor design and operating services.
AREVA is recognized by utilities around the world for its expertise, its skills in cutting-edge technologies and its dedication to the highest level of safety.
AREVA’s 41,000 employees are helping build tomorrow’s energy model: supplying ever safer, cleaner and more economical energy to the greatest number of people.

Tour AREVA – 1 Place Jean Millier – 92400 COURBEVOIE – France – Tel : +33 (0)1 34 96 00 00 – Fax : +33 (0)1 34 96 00 01

Nachrichten zu Areva S.A.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Areva S.A.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!